Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M91,576Revenue (TTM) $M51,786Net Margin (%)10.1Altman Z-Score2.0
Enterprise Value $M108,879EPS (TTM) $6.3Operating Margin %12.0Piotroski F-Score7
P/E(ttm)18.4Beneish M-Score-2.6Pre-tax Margin (%)13.2Higher ROA y-yY
Price/Book3.710-y EBITDA Growth Rate %5.8Quick Ratio1.0Cash flow > EarningsY
Price/Sales1.95-y EBITDA Growth Rate %7.6Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow15.1y-y EBITDA Growth Rate %16.8ROA % (ttm)6.2Higher Current Ratio y-yY
Dividend Yield %2.6PEG2.5ROE % (ttm)20.1Less Shares Outstanding y-yN
Payout Ratio %46.0Shares Outstanding M827ROIC % (ttm)10.5Gross Margin Increase y-yY

Gurus Latest Trades with BAYRY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BAYRY is held by these investors:



BAYRY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about BAYRY:

    News about BAYRY:

    Articles On GuruFocus.com
    2 Arbitrage Ideas From Warren Buffett and Seth Klarman Feb 23 2017 
    A Green Light on Bayer Jan 19 2017 
    Monsanto Posts Profitable Quarter From South American Growth Jan 06 2017 
    A Year in Review and Recommendations for 2017 Dec 27 2016 
    Warren Buffett's Financial Engineering Nov 15 2016 
    3 Chemical Companies From Polaris Global Value Oct 17 2016 
    Will the Monsanto-Bayer Deal Go Through? Sep 20 2016 
    Sanofi in a State of Suspended Animation Until Boehringer Ingelheim Swap Sep 19 2016 
    Monsanto Agrees to Bayer’s Proposal Sep 15 2016 
    Monsanto: What the Gurus May Be Telling Us About a Potential Buy-Out Sep 13 2016 

    More From Other Websites
    Prior job cuts lead to surplus of space, which Bayer now hopes to fill with startups Feb 24 2017
    [$$] Fusion Pharmaceuticals Raises $25 Million for Targeted Cancer Therapies Feb 23 2017
    2 Arbitrage Ideas From Warren Buffett and Seth Klarman Feb 23 2017
    Bayer (BAYRY) Misses on Q4 Earnings; Revenues in Line Feb 23 2017
    [$$] Bayer CEO Confident Monsanto Purchase Will Be Approved by End of Year Feb 23 2017
    [$$] Bayer Details Financing Plan for Monsanto Deal Feb 23 2017
    Bayer Offers Further Detail on Financing Monsanto Takeover Feb 22 2017
    [$$] Bayer Details Financing Plan for Monsanto Deal Feb 22 2017
    Bayer says Monsanto deal on track, eyes record 2017 Feb 22 2017
    Bayer sees pesticides profits stagnating before Monsanto takeover Feb 22 2017
    Bayer sees pesticides profits stagnating before Monsanto takeover Feb 22 2017
    Bayer sees pesticides profits stagnating before Monsanto takeover Feb 22 2017
    Bayer sees pesticides profits stagnating before Monsanto takeover Feb 22 2017
    [$$] Bayer CEO Confident Monsanto Purchase Will Be Approved by End of Year Feb 22 2017
    European Stocks Extend Gains as Economic Data Continues to Impress Feb 22 2017
    Bayer Shares Drop After Cautious 2017 Outlook For Crop Science Unit Feb 22 2017
    [$$] Strong pharmaceuticals earnings boost profits at Bayer Feb 22 2017
    Bayer Hints at Delay on Monsanto as Regulators Seek Details Feb 22 2017
    Bayer says Monsanto deal on track, eyes record 2017 Feb 21 2017
    Bayer ups dividend ahead of annual results Feb 20 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)